Hepatitis/MASH

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Hepatitis B therapeutic vaccine -- Image credit: syhin_stas | stock.adobe.com
Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB

May 3rd 2025

In chronic hepatitis B (CHB) mouse models, the ferritin nanoparticle-preS1 (ferritin-NP-preS1) with small interfering RNA (siRNA) showed 100% and sustained serum HBsAg over an approximate 11-month period.

Metabolic dysfunction-associated steatohepatitis -- Image credit: Angelov | stock.adobe.com
Engineered Extracellular Vesicles May Be a New Approach to Treating MASH

May 2nd 2025

Hepatitis B virus blood test -- Image credit: gamjai | stock.adobe.com
Investigators Anticipate Hydronidone Will Be Beneficial for Liver Fibrosis in CHB

April 24th 2025

Gene editing in chronic hepatitis B -- Image credit: 红 王 | stock.adobe.com
PBGENE-HBV Granted FDA Fast Track Designation for Chronic Hepatitis B

April 22nd 2025

Health care professional holding a hepatitis liver. -- Image credit: mi_viri | stock.adobe.com
Study: Hepatic PTPRD Expression Impaired in Etiologies of Chronic Liver Disease Associated With Metabolic Disease

April 15th 2025

<1
...